After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer
Satoshi Nakamura(Tokyo National Hospital), Jun Itami(National Cancer Centre Japan), Hiroyuki Okamoto(Tokyo National Hospital), Akihisa Wakita(Tokyo National Hospital), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Rei Umezawa(National Cancer Center Hospital East), Hiroshi Igaki(National Cancer Centre Japan), Koji Inaba(National Cancer Center), Naoya Murakami(Tokushima University Hospital), Yoshinori Ito(National Cancer Center Hospital East), Kazuma Kobayashi(Kinki Central Hospital), Madoka Morota(Japanese Foundation For Cancer Research), Kana Takahashi(Nihon University)
Cited by 10
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600